Literature DB >> 21350194

The transcription factor E74-like factor controls quiescence of endothelial cells and their resistance to myeloablative treatments in bone marrow.

Mariela Sivina1, Takeshi Yamada, Chun Shik Park, Monica Puppi, Suleyman Coskun, Karen Hirschi, H Daniel Lacorazza.   

Abstract

OBJECTIVE: The regeneration of the hematopoietic system in bone marrow after chemotherapy depends on a balance between the quiescence and proliferation of lineage-specific progenitor cells. Even though the vascular network in bone is damaged by cytoablation, the transcriptional control of quiescence in endothelial cells is not well known. In this study, we investigated the role of the transcription factor E74-like factor (ELF4) in the proliferation of endothelial cells in bone marrow. METHODS AND
RESULTS: Loss-of-function models were used to study the role of ELF4 in human and murine endothelial cells. ELF4 promotes cell cycle entry by activating cyclin-dependent kinase-4 in human umbilical vein endothelial cells. Elf4-null mice exhibited enhanced recovery of bone marrow CD45- CD31+ endothelial cells and sinusoidal blood vessels following administration of 5-fluorouracil.
CONCLUSIONS: Loss of ELF4 leads to increased quiescence in bone marrow endothelial cells by the deregulation of cyclin-dependent kinase-4 expression and to enhanced regeneration of sinusoidal blood vessels.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21350194      PMCID: PMC3100289          DOI: 10.1161/ATVBAHA.111.224436

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  33 in total

Review 1.  The ETS-domain transcription factor family.

Authors:  A D Sharrocks
Journal:  Nat Rev Mol Cell Biol       Date:  2001-11       Impact factor: 94.444

2.  The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells.

Authors:  H Daniel Lacorazza; Yasushi Miyazaki; Antonio Di Cristofano; Anthony Deblasio; Cyrus Hedvat; Jin Zhang; Carlos Cordon-Cardo; Shifeng Mao; Pier Paolo Pandolfi; Stephen D Nimer
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

3.  Opposing functions of the Ets factors NERF and ELF-1 during chicken blood vessel development.

Authors:  John Gaspar; Shelley Thai; Carole Voland; Antoinise Dube; Towia A Libermann; M Luisa Iruela-Arispe; Peter Oettgen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-07-01       Impact factor: 8.311

4.  Elf-1 is a transcriptional regulator of the Tie2 gene during vascular development.

Authors:  A Dube; S Thai; J Gaspar; S Rudders; T A Libermann; L Iruela-Arispe; P Oettgen
Journal:  Circ Res       Date:  2001-02-02       Impact factor: 17.367

5.  Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor.

Authors:  D D Spyropoulos; P N Pharr; K R Lavenburg; P Jackers; T S Papas; M Ogawa; D K Watson
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

6.  Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair.

Authors:  Myriam Alcalay; Natalia Meani; Vania Gelmetti; Anna Fantozzi; Marta Fagioli; Annette Orleth; Daniela Riganelli; Carla Sebastiani; Enrico Cappelli; Cristina Casciari; Maria Teresa Sciurpi; Angela Rosa Mariano; Simone Paolo Minardi; Lucilla Luzi; Heiko Muller; Pier Paolo Di Fiore; Guido Frosina; Pier Giuseppe Pelicci
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

7.  Comparative analysis of genes regulated by PML/RAR alpha and PLZF/RAR alpha in response to retinoic acid using oligonucleotide arrays.

Authors:  Dorothy J Park; Peter T Vuong; Sven de Vos; Dan Douer; H Phillip Koeffler
Journal:  Blood       Date:  2003-07-31       Impact factor: 22.113

Review 8.  The emerging role of the myeloid Elf-1 like transcription factor in hematopoiesis.

Authors:  H Daniel Lacorazza; Stephen D Nimer
Journal:  Blood Cells Mol Dis       Date:  2003 Nov-Dec       Impact factor: 3.039

9.  Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.

Authors:  Carsten Müller-Tidow; Björn Steffen; Thomas Cauvet; Lara Tickenbrock; Ping Ji; Sven Diederichs; Bülent Sargin; Gabriele Köhler; Matthias Stelljes; Elena Puccetti; Martin Ruthardt; Sven deVos; Scott W Hiebert; H Phillip Koeffler; Wolfgang E Berdel; Hubert Serve
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

10.  Transcription factor ELF4 controls the proliferation and homing of CD8+ T cells via the Krüppel-like factors KLF4 and KLF2.

Authors:  Takeshi Yamada; Chun Shik Park; Maksim Mamonkin; H Daniel Lacorazza
Journal:  Nat Immunol       Date:  2009-05-03       Impact factor: 25.606

View more
  3 in total

1.  The transcription factor E74-like factor 4 suppresses differentiation of proliferating CD4+ T cells to the Th17 lineage.

Authors:  Ping-Hsien Lee; Monica Puppi; Kimberly S Schluns; Li-Yuan Yu-Lee; Chen Dong; H Daniel Lacorazza
Journal:  J Immunol       Date:  2013-11-20       Impact factor: 5.422

Review 2.  Roles and regulations of the ETS transcription factor ELF4/MEF.

Authors:  Mary Ann Suico; Tsuyoshi Shuto; Hirofumi Kai
Journal:  J Mol Cell Biol       Date:  2017-06-01       Impact factor: 6.216

3.  ELF4 is critical for induction of type I interferon and the host antiviral response.

Authors:  Fuping You; Penghua Wang; Long Yang; Guang Yang; Yang O Zhao; Feng Qian; Wendy Walker; Richard Sutton; Ruth Montgomery; Rongtuan Lin; Akiko Iwasaki; Erol Fikrig
Journal:  Nat Immunol       Date:  2013-11-03       Impact factor: 25.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.